Agfa HealthCare to show unique web-enabled cardiovascular information system

AGFAAt the occasion of the World Congress of Cardiology in Barcelona, from September 2 until 6, Agfa HealthCare will demonstrate its leading cardiology solution: Agfa Heartlab Cardiovascular. The event also marks the European debut of Heartlab Congenital, the world's most comprehensive and flexible reporting and analysis tool for congenital echocardiography reporting.

Consolidating information from multiple cardiology subspecialties, Agfa Heartlab Cardiovascular improves departmental workflow, enables faster and more accurate diagnosis and creates a comprehensive digital cardiac record. More than twenty facilities on the world market have recently placed orders for Agfa's vendor neutral solution that connects all modality equipment. "Hospitals and clinics across Europe, Asia Pacific and the Middle East have entered into a contract with Agfa HealthCare to adopt the Heartlab Cardio suite, adding significantly to our global presence," said Reid Losee, Agfa's Global Cardiovascular Business Director. "The world market has recognized our clinical and technical expertise in the area of cardiology," she added.

Heart defects are among the most common birth defects and are the leading cause of birth-defect related deaths, according to the American Heart Association (AHA). Advances in diagnosis and surgical treatment have led to dramatic increases in survival for children with serious heart defects, the association has stated. As a result there is a growing population of adults with congenital heart disease. "We're excited to introduce our congenital product to the European market," said Dr. William Drake, Agfa's Congenital Heart Product Manager. "A large population of children and adults with congenital heart disease will benefit from these dynamic analysis and diagnostic tools."

Gayle J. Wheeler
MarCom Manager BU Cardiovascular
One Crosswind Road
RI 02891 Westerly, Rhode Island (USA)
tel:+1 (0)401 604 22 66
fax:+1 (0)401 596 85 62
This email address is being protected from spambots. You need JavaScript enabled to view it.

Johan Jacobs
Corporate Press Relations Manager
Septestraat 27
2640 Mortsel - Belgium
tel:+32 (0)3 444 80 15
fax:+32 (0)3 444 50 05
This email address is being protected from spambots. You need JavaScript enabled to view it.

Werner Vandevelde
Global MarCom Leader IT solutions HealthCare
Septestraat 27
2640 Mortsel - Belgium
tel:+32 (0)3 444 80 04
fax:+32 (0)3 444 72 85
This email address is being protected from spambots. You need JavaScript enabled to view it.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...